Department of Fetal Medicine and Prenatal Diagnosis Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
Prenat Diagn. 2024 Sep;44(10):1142-1149. doi: 10.1002/pd.6641. Epub 2024 Aug 8.
To assess the genetic etiologies underlying agenesis of the corpus callosum (ACC) and its pregnancy outcomes in the era of next-generation sequencing.
A retrospective analysis was conducted on prospectively collected prenatal ACC cases in which amniocentesis was performed between January 2016 and December 2022. ACC was divided into non-isolated and isolated according to the presence or absence of ultrasound abnormalities. Chromosomal microarray analysis (CMA), karyotyping and exome sequencing (ES) were performed after genetic counseling. Pregnancy outcomes were assessed by pediatric neurosurgeons and were followed up by telephone through their parents.
Sixty-eight fetuses with ACC were enrolled in this study. CMA detected eight cases with pathogenic copy number variants (CNVs) and all were non-isolated ACC, with a detection rate of 11.8% (8/68). Among the CMA abnormalities, the majority (6/8) were detectable by karyotyping. ES was performed in 26 cases with normal CMA, revealing pathogenic or likely pathogenic gene variations in 12 cases (46.2%, 12/26), involving L1CMA, SMARCB1, PPP2R1A, ARID1B, USP34, CDC42, NFIA and DCC genes. The detection rates of ES in isolated and non-isolated ACC were 40% (6/15) and 54.5% (6/11), respectively. After excluding cases where pregnancy was terminated (56 cases), there were 12 live births, ranging in age from 15 months to 7 years. Of these, 91.7% (11 out of 12) demonstrated normal neurodevelopmental outcomes. Specifically, all five cases with isolated ACC and negative ES results exhibited normal neurodevelopment. The remaining six cases with favorable outcomes were all isolated ACC, among which ES identified variants of DCC and USP34 gene in one each case. The other four cases were CMA-negative and declined ES.
We highlight the efficacy of prenatal ES in determining the genetic etiology of ACC, whether isolated or not. Favorable neurodevelopmental outcomes were observed when ACC was isolated and with normal ES results.
评估新一代测序时代胼胝体发育不全(ACC)的遗传病因及其妊娠结局。
对 2016 年 1 月至 2022 年 12 月期间行羊膜穿刺术的前瞻性收集的产前 ACC 病例进行回顾性分析。根据是否存在超声异常,将 ACC 分为非孤立型和孤立型。在遗传咨询后进行染色体微阵列分析(CMA)、核型分析和外显子组测序(ES)。由儿科神经外科医生评估妊娠结局,并通过其父母进行电话随访。
本研究共纳入 68 例 ACC 胎儿。CMA 检测到 8 例致病性拷贝数变异(CNVs),均为非孤立型 ACC,检出率为 11.8%(8/68)。在 CMA 异常中,大多数(6/8)可通过核型分析检测到。对 26 例 CMA 正常的病例进行 ES 检查,发现 12 例(46.2%,12/26)存在致病性或可能致病性基因变异,涉及 L1CMA、SMARCB1、PPP2R1A、ARID1B、USP34、CDC42、NFIA 和 DCC 基因。孤立型和非孤立型 ACC 的 ES 检出率分别为 40%(6/15)和 54.5%(6/11)。排除终止妊娠的病例(56 例)后,共有 12 例活产儿,年龄 15 个月至 7 岁。其中,91.7%(11 例)神经发育正常。具体来说,所有 5 例孤立型且 ES 结果阴性的病例神经发育均正常。其余 6 例预后良好的病例均为孤立型 ACC,其中 ES 分别在 1 例中发现 DCC 和 USP34 基因的变异,另外 4 例 CMA 阴性且拒绝 ES。
我们强调了产前 ES 在确定是否孤立的 ACC 的遗传病因方面的有效性。当 ACC 孤立且 ES 结果正常时,可观察到有利的神经发育结局。